2015
DOI: 10.1089/jwh.2015.29000-rwd
|View full text |Cite
|
Sign up to set email alerts
|

Osteoporosis After Long-Term Depot Medroxyprogesterone: We Need More Data on Fracture Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Conversely, others reported that women older than 40 years should be counseled to switch from injectables to POC, basing this on “clinical guidelines” that suggest that injectables might result in reduced bone density. However, the risk of osteoporosis and risk of fracture remains uncertain in long-term users of injectables, such as depot-medroxyprogesterone ( 29 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Conversely, others reported that women older than 40 years should be counseled to switch from injectables to POC, basing this on “clinical guidelines” that suggest that injectables might result in reduced bone density. However, the risk of osteoporosis and risk of fracture remains uncertain in long-term users of injectables, such as depot-medroxyprogesterone ( 29 ).…”
Section: Resultsmentioning
confidence: 99%
“…This highlights the importance of timeous communication to providers about guideline changes, and discussion. While the clinical implications for the risk due to reduced bone density amongst older women using DMPA remains uncertain ( 29 ), this finding highlights that lack of accurate knowledge may bias providers against providing women their preferred contraceptive method.…”
Section: Discussionmentioning
confidence: 99%